Order byBest matchMost fresh

Covid-19, FDA

Digest more
FDA may limit future Covid-19 shots to older people and those at risk of serious infection
The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit future shots to older Americans and people at higher risk of serious Covid-19 infection.

Continue reading

FDA Plans to Limit COVID-19 Vaccines to High-Risk Groups
New Trump vaccine policy limits access to COVID shots
US FDA advisers to consider if new COVID shots should target LP.8.1 subvariant
The U.S. Senate plans to vote this week to bar California's landmark plan to end the sale of gasoline-only vehicles by 2035 that has been adopted by 11 other states, Majority Leader John Thune said on...

Continue reading

Annual COVID-19 Shots For Healthy Younger Adults, Children Will No Longer Be Routinely Approved
US regulators say annual COVID-19 shots for healthy younger adults and children will no longer be routinely approved
F.D.A. Poised to Restrict Access to Covid Vaccines
The Food and Drug Administration will permit Covid vaccines for adults over 65 and those with certain medical conditions in the fall, according to new regulatory standards detailed on Tuesday by agen...

Continue reading

FDA to limit future Covid-19 shots to older people and those at risk of serious infection
FDA sets new COVID booster guidelines for healthy adults under 65
Who can get updated COVID vaccines this fall? FDA tightening rules
The decision means many Americans without underlying conditions may not have access to updated shots this fall."I think we have to admit to ourselves that America is deeply divided on the policy issue of repeat COVID-19 vaccine doses or boosters,
The FDA is making it more difficult for Americans to get vaccinated for covid
In the NEJM article, the FDA notes that covid booster uptake has been low in the US, with less than a quarter of people getting the shot each year. “There may even be a ripple effect: public trust in vaccination in general has declined,” it says.
Trump FDA overhauls COVID-19 vaccine approval to focus on older populations, high-risk individuals
The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the virus, and those older than age 65.
MedPage Today3h
FDA Panel to Consider COVID Vaccine Makeup for Next Season
The VRBPAC meeting comes the week after the World Health Organization (WHO) recommended that members consider using monovalent JN.1- or KP.2-lineage COVID-19 vaccine formulations -- the same as last year's -- with monovalent LP.8.1 lineage as a suitable alternative formulation.
FDA to Unveil Covid Shot Policy as RFK Jr. Eyes More Tests
President Donald Trump’s administration is slated to lay out its approach to Covid vaccination at an event Tuesday that could spell major changes in what is required to get regulatory approval for immunizations.
Explore more
Feedback